Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

Pokaż inne wersje (1)

BACKGROUND: Maternal antibodies give neonates some protection against bacterial infection. We measured antibodies against Neisseria meningitidis serogroups A, C, Y and W135 in mothers and their 2-month-old infants at study enrollment. We also assessed the impact of maternal antibody present at 2 mo...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Blanchard-Rohner, G, Snape, MD, Kelly, D, O'Connor, D, John, T, Kibwana, E, Parks, H, Ford, K, Dull, P, Pollard, A
Format:	Journal article
Język:	English
Wydane:	2013

Podobne zapisy

Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis serogroups A, C, y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom
od: Blanchard-Rohner, G, i wsp.
Wydane: (2013)

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children
od: Marzia Monica Giuliani, i wsp.
Wydane: (2021-05-01)

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.
od: Blanchard-Rohner, G, i wsp.
Wydane: (2013)

Neisseria meningitidis Serogroup W135, China
od: Zhujun Shao, i wsp.
Wydane: (2010-02-01)

The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age
od: Blanchard-Rohner, G, i wsp.
Wydane: (2013)

Pericarditis due to Neisseria meningitidis serogroup W135
od: Takashi Shinha, i wsp.
Wydane: (2018-01-01)

Carriage of Neisseria meningitidis Serogroup W135 ST-2881
od: Pascal Boisier, i wsp.
Wydane: (2006-09-01)

Hajj-Related Neisseria Meningitidis Serogroup W135 in Mauritius
od: Mohammad Iqbal Issack, i wsp.
Wydane: (2002-03-01)

Travel-related Neisseria meningitidis Serogroup W135 Infection, France
od: Muhamed-Kheir Taha, i wsp.
Wydane: (2013-06-01)

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
od: Hoan Jong Lee, i wsp.
Wydane: (2014-11-01)

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?
od: Katharina Schley, i wsp.
Wydane: (2023-05-01)

Neisseria meningitidis Serogroup W135 Isolates Associated with the ET-37 Complex
od: Tanja Popovic, i wsp.
Wydane: (2000-08-01)

Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines
od: Lidia Serra, i wsp.
Wydane: (2021-07-01)

Real-world impact and effectiveness of MenACWY-TT
od: Rodolfo Villena, i wsp.
Wydane: (2023-08-01)

Towards an improved serogroup B Neisseria meningitidis vaccine.
od: Perrett, K, i wsp.
Wydane: (2005)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
od: Khatami, A, i wsp.
Wydane: (2012)

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.
od: Khatami, A, i wsp.
Wydane: (2012)

New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.
od: Suzanne Chanteau, i wsp.
Wydane: (2006-09-01)

Recent Increase in Meningitis Caused by Neisseria meningitidis Serogroups A and W135, Yaoundé, Cameroon
od: Marie-Christine Fonkoua, i wsp.
Wydane: (2002-03-01)

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
od: Carr, JP, i wsp.
Wydane: (2022)

A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty
od: Andrews, S, i wsp.
Wydane: (2014)

A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.
od: Andrews, S, i wsp.
Wydane: (2014)

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.
od: Xie, O, i wsp.
Wydane: (2012)

Neisseria meningitidis W135, Turkey
od: Levent Doganci, i wsp.
Wydane: (2004-05-01)

Neisseria meningitidis Strain of Unknown Serogroup, China
od: Haijian Zhou, i wsp.
Wydane: (2011-03-01)

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
od: María Gabriela Graña, i wsp.
Wydane: (2021-12-01)

Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination
od: Cynthia Burman, i wsp.
Wydane: (2024-12-01)

A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
od: Jacopo Enotarpi, i wsp.
Wydane: (2020-09-01)

Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil
od: David E Barroso, i wsp.
Wydane: (2007-09-01)

Characterization of Unusual Serogroups of <i>Neisseria meningitidis</i>
od: Samy Taha, i wsp.
Wydane: (2024-12-01)

Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
od: Jacob Strahilevitz, i wsp.
Wydane: (2008-10-01)

The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
od: Valerian B Pinto, i wsp.
Wydane: (2013-01-01)

Spread of Neisseria meningitidis Serogroup W Clone, China
od: Haijian Zhou, i wsp.
Wydane: (2013-09-01)

Neisseria meningitidis Serogroup W, Burkina Faso, 2012
od: Jessica R. MacNeil, i wsp.
Wydane: (2014-03-01)

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
od: Timo Vesikari, i wsp.
Wydane: (2020-06-01)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
od: Blanchard-Rohner, G, i wsp.
Wydane: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
od: Blanchard-Rohner, G, i wsp.
Wydane: (2012)

Distribution of Serogroups and Genotypes among Neisseria Meningitidis Strains in Malaysia
od: Kuppusamy, Puvanesvari
Wydane: (2009)

Neisseria meningitidis serogroup X sequence type 767 in Turkey.
od: Kiliç, A, i wsp.
Wydane: (2010)

Correction: Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil
Wydane: (2012-01-01)